These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9596005)

  • 1. Acute delirium after withdrawal of amantadine in Parkinson's disease.
    Factor SA; Molho ES; Brown DL
    Neurology; 1998 May; 50(5):1456-8. PubMed ID: 9596005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute delirium after withdrawal of amantadine in Parkinson's disease.
    Miyasaki JM; Grimes D; Lang AE
    Neurology; 1999 May; 52(8):1720-1. PubMed ID: 10331717
    [No Abstract]   [Full Text] [Related]  

  • 3. Visual hallucinations and delirium during treatment with amantadine (Symmetrel).
    Postma JU; Van Tilburg W
    J Am Geriatr Soc; 1975 May; 23(5):212-5. PubMed ID: 123540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma amantadine concentrations in patients with Parkinson's disease.
    Nishikawa N; Nagai M; Moritoyo T; Yabe H; Nomoto M
    Parkinsonism Relat Disord; 2009 Jun; 15(5):351-3. PubMed ID: 18823813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Amantadine Withdrawal in 3 Cases of Treatment-Refractory Altered Mental Status.
    Fryml LD; Williams KR; Pelic CG; Fox J; Sahlem G; Robert S; Revuelta GJ; Short EB
    J Psychiatr Pract; 2017 May; 23(3):191-199. PubMed ID: 28492457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dropped head associated with amantadine in Parkinson disease.
    Kataoka H; Ueno S
    Clin Neuropharmacol; 2011; 34(1):48-9. PubMed ID: 21242745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amantadine withdrawal in a patient with spinocerebellar ataxia.
    Pak A; Chang E
    BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37963666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient amantadine-induced musical hallucinations in a patient with Parkinson's disease.
    Gondim Fde A; Costa HA; Taunay TC; de Oliveira GR; Ferreira JM; Rola FH
    Mov Disord; 2010 Jul; 25(10):1505-6. PubMed ID: 20629118
    [No Abstract]   [Full Text] [Related]  

  • 9. Four-year treatment of patients with parkinsonism using amantadine alone or with levodopa.
    Timberlake WH; Vance MA
    Ann Neurol; 1978 Feb; 3(2):119-28. PubMed ID: 350129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delirium with manic and psychotic features associated with amantadine.
    Neagoe AD
    Gen Hosp Psychiatry; 2013; 35(6):680.e7-8. PubMed ID: 23731892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amantadine withdrawal and neuroleptic malignant syndrome.
    Weller M; Kornhuber J
    Neurology; 1993 Oct; 43(10):2155. PubMed ID: 8413995
    [No Abstract]   [Full Text] [Related]  

  • 12. Bupropion and delirium.
    Liberzon I; Dequardo JR; Silk KR
    Am J Psychiatry; 1990 Dec; 147(12):1689-90. PubMed ID: 2123081
    [No Abstract]   [Full Text] [Related]  

  • 13. Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series.
    Singer C; Papapetropoulos S; Gonzalez MA; Roberts EL; Lieberman A
    Mov Disord; 2005 Jul; 20(7):873-7. PubMed ID: 15809995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amantadine induced reversible corneal edema.
    Deogaonkar M; Wilson K; Vitek J
    J Clin Neurosci; 2011 Feb; 18(2):298-9. PubMed ID: 21163653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amantadine in the treatment of Parkinson's disease].
    Penders C
    Rev Med Liege; 1972 Dec; 27(23):835-7. PubMed ID: 4276353
    [No Abstract]   [Full Text] [Related]  

  • 16. [Amantadine therapy of Parkinson's syndrome. Comment on L.W. Diehl: "Nil nocere. Adverse effects of amantadine therapy of parkinsnism"].
    Völler G
    Munch Med Wochenschr; 1972 Jun; 114(22):1066-7. PubMed ID: 5068022
    [No Abstract]   [Full Text] [Related]  

  • 17. Toxic delirium in a patient taking amantadine and trimethoprim-sulfamethoxazole.
    Speeg KV; Leighton JA; Maldonado AL
    Am J Med Sci; 1989 Dec; 298(6):410-2. PubMed ID: 2596498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal-induced neuroleptic malignant syndrome.
    Bower DJ; Chalasani P; Ammons JC
    Am J Psychiatry; 1994 Mar; 151(3):451-2. PubMed ID: 8109662
    [No Abstract]   [Full Text] [Related]  

  • 19. Mental symptoms in Parkinson's disease during chronic treatment with levodopa.
    Sweet RD; McDowell FH; Feigenson JS; Loranger AW; Goodell H
    Neurology; 1976 Apr; 26(4):305-10. PubMed ID: 944387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial of amantadine in Parkinson's disease.
    Campbell AM; Williams MJ
    Br J Clin Pract; 1972 Jan; 26(1):19-22. PubMed ID: 4554563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.